Press Release

Aspirin Market to grow at an impressive rate During the Forecast Period

Increasing use of aspirin as over the counter medication is expected to drive the growth of India aspirin market.

According to TechSci Research report, India Aspirin Market By Product Type (Prescription v/s OTC), By Form (Tablet, Capsule, Solution), By Route of Administration (Oral v/s Intravenous), By Source (In-House v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By Application (Cardiovascular Diseases, Pain, Fever, Arthritis, Others), By End User (Children ≥14 years v/s Adults), By Company, By Region, Forecast & Opportunities, FY2026, the India aspirin market is expected to grow at an impressive rate during the forecast period on account of the use of aspirin for multiple purposes such as an analgesic, in fever, in cardiovascular diseases, in rheumatoid arthritis for reducing swelling and inflammation, among others. Additionally, the easy availability and low cost of aspirin are expected to propel the market growth over the next few years. Besides, proven safety and efficacy of aspirin have further increased its demand. However, side-effects such as nausea, indigestion, irritation in stomach, among others can hamper the market growth through FY2026. Moreover, in certain cases serious side effects such as bruising, vomiting, stomach bleeding, among others can be observed due to intake of aspirin. Also, aspirin is not recommended for patients having peptic ulcers, hemophilia or any other bleeding disorder, asthma, among others. Furthermore, patients who are allergic to any NSAID such as ibuprofen are also not recommended to use and consume aspirin. All these factors are expected to restrict the market growth over the next few years.

Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on " India Aspirin Market"

https://www.techsciresearch.com/report/india-aspirin-market/5130.html

The India aspirin market is segmented based on product type, form, route of administration, source, distribution channel, application, end user, company and region. Based on form, the market can be fragmented into tablet, capsule and solution. The tablet segment is expected to dominate the market during forecast period. This can be ascribed to their durability, safety, efficacy in delivering oral medications, cost-effectiveness, easy availability, among others. Additionally, a single tablet can accommodate a higher dose of active pharmaceutical ingredient (API) as compared to capsule. Based on distribution channel, the market can be split into online and offline. The offline segment is expected to dominate the market through FY2026. This can be ascribed to the widespread network of pharmacies and drug stores where the drug is easily available both as a prescription medicine and as an OTC drug. Based on application, the market can be categorized into cardiovascular diseases, pain, fever, arthritis and others. The pain segment is expected to dominate the market owing to the widespread use of aspirin as a quick, effective and excellent pain reliver. The cardiovascular diseases segment is expected to witness significant growth during the forecast period. This can be attributed to the use of aspirin in stroke prevention, blood thinning, among others.

Eli Lilly and Company (India) Pvt. Ltd., AstraZeneca Pharma India Limited, The Andhra Sugars Limited, Unnati Pharmaceuticals Pvt. Ltd., Taj Pharmaceuticals Limited, Trumac Healthcare, Zydus Healthcare Ltd., Cipla Limited, Reckitt Benckiser (India) Ltd, Natco Pharma Limited and others are some of the leading players operating in India aspirin market. Companies operating in the market are using organic strategies such as product launches, mergers and collaborations to boost their share.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=5130

Customers can also request for 10% free customization on this report.

India aspirin market is expected to witness growth during the forecast period on account of its versatility as an analgesic and prescription drug especially in case of cardiovascular disorders and stroke prevention. Additionally, aspirin is one of the most trusted over the counter drug that is available and present in the market for more than 120 years. Furthermore, supportive government policies such as the Pharma Vision 2020, scheme for establishing bulk drug parks and launch of incentive scheme for indigenous manufacturing of 53 APIs in India of which aspirin is one, is expected to create lucrative opportunities for the market growth through FY2026.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based India management consulting firm.

India Aspirin Market By Product Type (Prescription v/s OTC), By Form (Tablet, Capsule, Solution), By Route of Administration (Oral v/s Intravenous), By Source (In-House v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By Application (Cardiovascular Diseases, Pain, Fever, Arthritis, Others), By End User (Children ≥14 years v/s Adults), By Company, By Region, Forecast & Opportunities, FY2026”, has evaluated the future growth potential of India aspirin market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in India aspirin market.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

 

Tel: +1-646-360-1656

 

Email: [email protected]

Relevant News